Vistagen Therapeutics, Inc.
VTGN
Revenue
176.00k
▼-4.00k▼-2.22%
3 Months ChangeAssets
65.06M
▼-15.87M▼-19.61%
3 Months ChangeLiabilities
14.14M
▼-454.00k▼-3.11%
3 Months ChangeFree Cash Flow
-16.14M
▼-9.82M▼-155.32%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-20
Form 8-K
ID: 0001628280-26-010035
2026-02-12
Form 10-Q
ID: 0001628280-26-007718
2026-02-12
Form 8-K
ID: 0001628280-26-007715
2026-02-06
Form 8-K
ID: 0001628280-26-006078
2026-01-09
Form 8-K
ID: 0001628280-26-001690
2025-12-22
Form 8-K
ID: 0001628280-25-058594
2025-12-03
Form 8-K
ID: 0001628280-25-055083
2025-11-13
Form 10-Q
ID: 0001628280-25-052079
2025-11-13
Form 8-K
ID: 0001628280-25-052077
2025-11-04
Form 8-K
ID: 0001628280-25-048827